Evolving Concepts of Pharmaceutical Company–Sponsored Surveillance Studies

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Atrial Remodeling: Evolving Concepts

The term "Electrophysiological remodeling" defines the changes of atrial electrophysiologic properties taking place in atrial myocites during atrial fibrillation and/or following periods of sustained atrial fibrillation (AF). Early research was prompted by clinical observations: many patients were seen to get through increasingly frequent and longer paroxisms of AF to persistent AF, until chron...

متن کامل

Evolving concepts of sensory adaptation

Sensory systems constantly adapt their responses to match the current environment. These adjustments occur at many levels of the system and increasingly appear to calibrate even for highly abstract perceptual representations of the stimulus. The similar effects of adaptation across very different stimulus domains point to common design principles but also continue to raise questions about the p...

متن کامل

Evolving concepts of chemical sensitivity.

Chemical sensitivity appears to be an elusive phenomenon. Studies on individual differences in susceptibility may provide glimpses into the range of sensitivity in a population, which can be used for further study. Preliminary evidence in laboratory animals suggests the range of sensitivity to manufactured chemicals may span orders of magnitude. Determining the reasons that underlie individual ...

متن کامل

Evolving concepts of neonatal skin.

Skin barrier function is crucial to health. Importantly, the skin operates as an air-liquid, a liquid-liquid, and an immunological barrier. The skin's physical and chemical structures, as well as its microbiome, function to create, maintain, and repair this complex barrier.

متن کامل

Automating Pharmaceutical Safety Surveillance process

Pharmaceutical companies invest huge amount of effort and cost in launching a drug into the market, keeping the two aspects in mind i.e. safety and efficacy. Post launching the drugs into the market, the organisations then need to monitor the adverse events from these drugs, and need to take the action accordingly. In this white paper few approaches are discussed for automating the post market ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Clinical Infectious Diseases

سال: 2005

ISSN: 1058-4838,1537-6591

DOI: 10.1086/430791